Frank J, Jugert F K, Kalka K, Goerz G, Merk H F, Christiano A M
Department of Dermatology, Columbia University, New York, New York 10032, USA.
J Invest Dermatol. 1998 Apr;110(4):449-51. doi: 10.1046/j.1523-1747.1998.00147.x.
The porphyrias are disorders of porphyrin metabolism that result from inherited or acquired aberrations in the control of the heme biosynthetic pathway. Variegate porphyria is characterized by a partial reduction in the activity of protoporphyrinogen oxidase. In this study, we identified the first nonsense mutation in a family with variegate porphyria. The mutation consisted of a previously unreported G-to-T transversion in exon 5 of the protoporphyrinogen oxidase gene, resulting in the substitution of glutamic acid by a nonsense codon, designated E133X. Our investigation establishes that a nonsense mutation in the protoporphyrinogen oxidase gene is the underlying mutation in this family with variegate porphyria.
卟啉症是卟啉代谢紊乱疾病,由遗传性或后天性血红素生物合成途径调控异常引起。杂合性卟啉症的特征是原卟啉原氧化酶活性部分降低。在本研究中,我们在一个杂合性卟啉症家族中鉴定出首个无义突变。该突变由原卟啉原氧化酶基因第5外显子中一个此前未报道的G到T的颠换组成,导致谷氨酸被一个无义密码子取代,命名为E133X。我们的研究证实,原卟啉原氧化酶基因中的无义突变是这个杂合性卟啉症家族的潜在突变。